United States· US:64842-0120_87b2e0c4-3351-4a85-b721-19a0574daafa

LYTGOBI

A futibatinib product containing futibatinib, registered in United States by TAIHO PHARMACEUTICAL CO., LTD.. The same ATC class is registered in 12 of our 19 countries.

ATC L01EN04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLYTGOBIATCL01EN04REGISTER NO.US:64842-0120_87b2e0c…PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Futibatinib is registered in 12 of 19 countries.

Countries holding a registration under ATC L01EN04 (futibatinib), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Futibatinib · ATC L01EN04

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of futibatinib costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.36 in France to $366.73 in Switzerland — a ×1007 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Futibatinib · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$366.73
  • FR France$0.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FUTIBATINIB
Manufacturer
TAIHO PHARMACEUTICAL CO., LTD.
Country
United States (US)
ATC code
L01EN04
ATC class
Futibatinib
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    64842-0120-4
  • ndc11
    64842-0120-5
  • ndc11
    64842-0120-6
  • ndc11
    6484201204
    1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACK
  • ndc11
    6484201205
    1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACK
  • ndc11
    6484201206
    1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7e352b6-b859-48cc-b21b-e1226a92e681
GET /v1/drugs/c7e352b6-b859-48cc-b21b-e1226a92e681?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "4",
  "substance": "FUTIBATINIB",
  "productndc": "64842-0120",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA214801",
  "marketing_category": "NDA"
}

See everything about futibatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.